Prostaglandin D synthase (β trace) levels in sleep apnea patients with and without sleepiness

Sleep Medicine

Volumn 8, Issue 5, 2007, Pages 509-511

  Barcelo A ^a   de la Pena M ^a   Barbe F ^c   Pierola, J ^a,b   Bosch, M ^a,b   Agusti A G N ^a,b  

^a Servei de Analisis Cliniques and Pneumologia   (Spain)

^b HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^c HOSPITAL ARNAU DE VILANOVA   (Spain)

Author keywords

Obstructive sleep apnea; Prostaglandin; Sleepiness

Indexed keywords

LIPOCALIN; PROSTAGLANDIN D SYNTHASE; PROSTAGLANDIN D2;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DAYTIME SOMNOLENCE; ENZYME ACTIVITY; HUMAN; HYPOTHESIS; MALE; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SLEEP APNEA SYNDROME;

ADULT; CIRCADIAN RHYTHM; DISORDERS OF EXCESSIVE SOMNOLENCE; FEMALE; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; RADIOIMMUNOASSAY; SLEEP APNEA, OBSTRUCTIVE;

EID: 34250796764     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2006.10.005     Document Type: Article

References (17)

1. Douglas N.J., and Polo O. Pathogenesis of sleep apnoea/hypopnoea syndrome. Lancet 344 (1994) 653-655
2. Goncalves M.A., Paiva T., Ramos E., and Guilleminault C. Obstructive sleep apnea syndrome, sleepiness, and quality of life. Chest 125 6 (2004) 2091-2096
3. Barbe F., Mayoralas L.R., Duran J., et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness, a randomized, controlled trial. Ann Intern Med 134 11 (2001) 1015-1023
4. Hayaishi O. Prostaglandin D2 and sleep. Ann NY Acad Sci 559 (1989) 374-381
5. Hayaishi O. Molecular mechanisms of sleep-wake regulation: roles of prostaglandins D2 and E2. FASEB J 5 11 (1991) 2575-2581
6. Jordan W., Tumani H., Cohrs S., et al. Narcolepsy Increased L-PGDS (beta-trace) levels correlate with excessive daytime sleepiness but not with cataplexy. J Neurol June 21 (2005)
7. Urade Y., and Hayaishi O. Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandin D synthase. Biochim Biophys Acta 1482 1-2 (2000) 259-271
8. Jordan W., Tumani H., Cohrs S., et al. Prostaglandin D synthase (beta-trace) in healthy human sleep. Sleep 27 5 (2004) 867-874
9. Johns M.W. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14 (1991) 540-545
10. Carskadon M.A., Dement W.C., Mitler M.M., Roth T., Westbrook P.R., and Keenan S. Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep 9 4 (1986) 519-524
11. Hayaishi O. Molecular genetic studies on sleep-wake regulation, with special emphasis on the prostaglandin D(2) system. J Appl Physiol 92 2 (2002) 863-868
12. Jordan W., Hagedohm J., Wiltfang J., et al. Biochemical markers of cerebrovascular injury in sleep apnoea syndrome. Eur Respir J 20 1 (2002) 158-164
13. Melegos D.N., Freedman M.S., and Diamandis E.P. Prostaglandin D synthase concentration in cerebrospinal fluid and serum of patients with neurological disorders. Prostaglandins 54 1 (1997) 463-474
14. Melegos D.N., Grass L., Pierratos A., and Diamandis E.P. Highly elevated levels of prostaglandin D synthase in the serum of patients with renal failure. Urology 53 1 (1999) 32-37
15. Hirawa N., Uehara Y., Yamakado M., et al. Lipocalin-type prostaglandin d synthase in essential hypertension. Hypertension 39 2 Pt 2 (2002) 449-454
16. Gozal D., and Kheirandish L. Sleepiness and neurodegeneration in sleep-disordered breathing: convergence of signaling cascades. Am J Respir Crit Care Med 171 12 (2005) 1325-1327
17. Li R.C., Row B.W., Gozal E., et al. Cyclooxygenase 2 and intermittent hypoxia-induced spatial deficits in the rat. Am J Respir Crit Care Med 168 4 (2003) 469-475